Lecalcif (Colecalciferol)

Colecalciferol (vitamin D3) is converted in the liver to 25‑hydroxyvitamin D and then in the kidney to the active hormone 1,25‑dihydroxyvitamin D. This active form binds to vitamin D receptors in various tissues, stimulating the absorption of calcium and phosphate from the gut and promoting bone mineralization.

The appropriate dose of Lecalcif is individualized by a healthcare professional based on factors such as the patient’s serum vitamin D level, age, underlying health conditions, and concurrent medications. The prescriber sets the dosage and duration according to clinical guidelines and the patient’s specific needs.

Safety of lecacif (colecalciferol) in pregnancy or lactation should be evaluated by a qualified clinician. Vitamin D is essential for fetal bone development, but dosing must be appropriate. Pregnant or nursing individuals should only use the product if prescribed after a risk‑benefit assessment.

To order Lecalcif, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Lecalcif contains colecalciferol, the same form of vitamin D3 found in many over‑the‑counter supplements. Its quality is ensured by GNH India’s GMP‑compliant manufacturing and EU market approval. Compared with some alternatives that may use vitamin D2 (ergocalciferol), colecalciferol generally offers better bioavailability and longer duration of action.

Lecalcif should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Lecalcif is taken orally, usually with or without food, as directed by a healthcare professional. The tablet or capsule is swallowed whole with a glass of water. Patients should follow the prescriber’s instructions regarding timing and any specific dietary considerations.

The most serious risks involve excessive vitamin D levels leading to severe hypercalcemia, which can cause cardiac arrhythmias, renal impairment, or kidney stone formation. Rarely, allergic reactions such as rash, swelling, or anaphylaxis may occur. Monitoring calcium levels and adhering to prescribed doses help mitigate these risks.

Individuals with known hypersensitivity to colecalciferol or any excipients in the formulation should avoid Lecalcif. Patients with uncontrolled hypercalcemia, severe renal disease, or granulomatous disorders such as sarcoidosis should consult a physician before use, as they may be at higher risk for adverse effects.